Skip to main content
Nina Wagner-Johnston, MD, Oncology, Baltimore, MD

Nina Delaney Wagner-Johnston MD


Assistant Professor, Internal Medicine, Washington University School of Medicine

Join to View Full Profile
  • 401 North Broadway StreetWeinberg BLDGBaltimore, MD 21287

  • Phone+1 410-955-8964

  • Fax+1 410-367-2194

Dr. Wagner-Johnston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2003 - 2005
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2022 - 2026
  • MD State Medical License
    MD State Medical License 2005 - 2025
  • PA State Medical License
    PA State Medical License 2024 - 2024
  • MO State Medical License
    MO State Medical License 2008 - 2016
  • IL State Medical License
    IL State Medical License 2003 - 2006
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase IB Study of Blinatumomab (blina) in Patients with B Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or M...
    Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Pat...
    Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 Patients
    Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/ Waldenstrom's Macroglobulinemia 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Treatment Options in MCL: What Are the Best Practices?
    Treatment Options in MCL: What Are the Best Practices?September 12th, 2024
  • Pain Pointers
    Pain PointersJune 1st, 2021
  • Dual Expression of MYC, BCL2 Associated with Poorer Outcomes in DLBCL
    Dual Expression of MYC, BCL2 Associated with Poorer Outcomes in DLBCLMay 26th, 2017

Grant Support

  • Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research FootprintJOHNS HOPKINS UNIVERSITY2023–2028
  • Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research FootprintJOHNS HOPKINS UNIVERSITY2023–2028

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: